nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP19A1—polycystic ovary syndrome	0.775	1	CbGaD
Letrozole—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0497	0.407	CbGeAlD
Letrozole—CYP19A1—corpus luteum—polycystic ovary syndrome	0.0286	0.235	CbGeAlD
Letrozole—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.0224	0.184	CbGeAlD
Letrozole—CYP19A1—Ovarian Infertility Genes—GDF9—polycystic ovary syndrome	0.00504	0.0845	CbGpPWpGaD
Letrozole—CYP3A4—urine—polycystic ovary syndrome	0.00454	0.0373	CbGeAlD
Letrozole—Bifonazole—CYP17A1—polycystic ovary syndrome	0.00368	0.663	CrCbGaD
Letrozole—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00255	0.0209	CbGeAlD
Letrozole—CYP19A1—endometrium—polycystic ovary syndrome	0.00222	0.0182	CbGeAlD
Letrozole—CYP2A6—vagina—polycystic ovary syndrome	0.00212	0.0174	CbGeAlD
Letrozole—CYP19A1—uterus—polycystic ovary syndrome	0.00204	0.0167	CbGeAlD
Letrozole—CYP19A1—adipose tissue—polycystic ovary syndrome	0.002	0.0164	CbGeAlD
Letrozole—CYP19A1—Ovarian Infertility Genes—LHCGR—polycystic ovary syndrome	0.00193	0.0324	CbGpPWpGaD
Letrozole—Bifonazole—CYP19A1—polycystic ovary syndrome	0.00187	0.337	CrCbGaD
Letrozole—CYP19A1—adrenal gland—polycystic ovary syndrome	0.00179	0.0147	CbGeAlD
Letrozole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00168	0.0282	CbGpPWpGaD
Letrozole—CYP19A1—female gonad—polycystic ovary syndrome	0.00167	0.0137	CbGeAlD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A1—polycystic ovary syndrome	0.00162	0.0272	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—FSHR—polycystic ovary syndrome	0.00162	0.0271	CbGpPWpGaD
Letrozole—CYP19A1—endocrine gland—polycystic ovary syndrome	0.00155	0.0127	CbGeAlD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—polycystic ovary syndrome	0.00155	0.0259	CbGpPWpGaD
Letrozole—Lightheadedness—Metformin—polycystic ovary syndrome	0.00145	0.0384	CcSEcCtD
Letrozole—CYP19A1—Ovarian Infertility Genes—FSHR—polycystic ovary syndrome	0.00141	0.0237	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD3B1—polycystic ovary syndrome	0.00132	0.0221	CbGpPWpGaD
Letrozole—CYP19A1—Endogenous sterols—CYP11A1—polycystic ovary syndrome	0.00124	0.0207	CbGpPWpGaD
Letrozole—Lethargy—Metformin—polycystic ovary syndrome	0.0012	0.0318	CcSEcCtD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—LHB—polycystic ovary syndrome	0.0012	0.0201	CbGpPWpGaD
Letrozole—CYP2A6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00119	0.02	CbGpPWpGaD
Letrozole—Pain in extremity—Metformin—polycystic ovary syndrome	0.00118	0.0311	CcSEcCtD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.00117	0.0197	CbGpPWpGaD
Letrozole—CYP19A1—Endogenous sterols—CYP17A1—polycystic ovary syndrome	0.00115	0.0193	CbGpPWpGaD
Letrozole—Breast disorder—Metformin—polycystic ovary syndrome	0.00106	0.0281	CcSEcCtD
Letrozole—Influenza—Metformin—polycystic ovary syndrome	0.00102	0.0269	CcSEcCtD
Letrozole—Angina pectoris—Metformin—polycystic ovary syndrome	0.00099	0.0262	CcSEcCtD
Letrozole—Sweating increased—Metformin—polycystic ovary syndrome	0.00099	0.0262	CcSEcCtD
Letrozole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.000937	0.0157	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.000926	0.0155	CbGpPWpGaD
Letrozole—Infestation—Metformin—polycystic ovary syndrome	0.000906	0.024	CcSEcCtD
Letrozole—Infestation NOS—Metformin—polycystic ovary syndrome	0.000906	0.024	CcSEcCtD
Letrozole—CYP19A1—Ovarian Infertility Genes—PGR—polycystic ovary syndrome	0.000873	0.0146	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.00086	0.0144	CbGpPWpGaD
Letrozole—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000857	0.0227	CcSEcCtD
Letrozole—CYP2A6—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000852	0.0143	CbGpPWpGaD
Letrozole—Hepatitis—Metformin—polycystic ovary syndrome	0.000813	0.0215	CcSEcCtD
Letrozole—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000809	0.0214	CcSEcCtD
Letrozole—CYP2A6—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.000805	0.0135	CbGpPWpGaD
Letrozole—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000801	0.0212	CcSEcCtD
Letrozole—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000799	0.0212	CcSEcCtD
Letrozole—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00078	0.0131	CbGpPWpGaD
Letrozole—Eye disorder—Metformin—polycystic ovary syndrome	0.00076	0.0201	CcSEcCtD
Letrozole—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000755	0.02	CcSEcCtD
Letrozole—Flushing—Metformin—polycystic ovary syndrome	0.000755	0.02	CcSEcCtD
Letrozole—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000753	0.00618	CbGeAlD
Letrozole—Angiopathy—Metformin—polycystic ovary syndrome	0.000738	0.0195	CcSEcCtD
Letrozole—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000733	0.0194	CcSEcCtD
Letrozole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000721	0.0121	CbGpPWpGaD
Letrozole—Malnutrition—Metformin—polycystic ovary syndrome	0.000708	0.0188	CcSEcCtD
Letrozole—Dysgeusia—Metformin—polycystic ovary syndrome	0.000693	0.0184	CcSEcCtD
Letrozole—Vision blurred—Metformin—polycystic ovary syndrome	0.000667	0.0177	CcSEcCtD
Letrozole—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000657	0.0174	CcSEcCtD
Letrozole—CYP2A6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000652	0.0109	CbGpPWpGaD
Letrozole—Malaise—Metformin—polycystic ovary syndrome	0.000638	0.0169	CcSEcCtD
Letrozole—CYP2A6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000627	0.0105	CbGpPWpGaD
Letrozole—Palpitations—Metformin—polycystic ovary syndrome	0.000626	0.0166	CcSEcCtD
Letrozole—Hypertension—Metformin—polycystic ovary syndrome	0.000611	0.0162	CcSEcCtD
Letrozole—Chest pain—Metformin—polycystic ovary syndrome	0.000603	0.016	CcSEcCtD
Letrozole—Myalgia—Metformin—polycystic ovary syndrome	0.000603	0.016	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000599	0.0159	CcSEcCtD
Letrozole—Discomfort—Metformin—polycystic ovary syndrome	0.000596	0.0158	CcSEcCtD
Letrozole—CYP19A1—Ovarian Infertility Genes—NCOR1—polycystic ovary syndrome	0.000593	0.00995	CbGpPWpGaD
Letrozole—Oedema—Metformin—polycystic ovary syndrome	0.000578	0.0153	CcSEcCtD
Letrozole—Infection—Metformin—polycystic ovary syndrome	0.000574	0.0152	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000574	0.00962	CbGpPWpGaD
Letrozole—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000567	0.015	CcSEcCtD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000566	0.00949	CbGpPWpGaD
Letrozole—Skin disorder—Metformin—polycystic ovary syndrome	0.000561	0.0149	CcSEcCtD
Letrozole—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000559	0.0148	CcSEcCtD
Letrozole—Anorexia—Metformin—polycystic ovary syndrome	0.000551	0.0146	CcSEcCtD
Letrozole—CYP19A1—Endogenous sterols—POMC—polycystic ovary syndrome	0.000546	0.00916	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000537	0.00901	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000533	0.00894	CbGpPWpGaD
Letrozole—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000526	0.0139	CcSEcCtD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000526	0.00883	CbGpPWpGaD
Letrozole—Paraesthesia—Metformin—polycystic ovary syndrome	0.000519	0.0137	CcSEcCtD
Letrozole—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000518	0.00869	CbGpPWpGaD
Letrozole—Dyspnoea—Metformin—polycystic ovary syndrome	0.000515	0.0136	CcSEcCtD
Letrozole—Somnolence—Metformin—polycystic ovary syndrome	0.000514	0.0136	CcSEcCtD
Letrozole—Dyspepsia—Metformin—polycystic ovary syndrome	0.000509	0.0135	CcSEcCtD
Letrozole—Decreased appetite—Metformin—polycystic ovary syndrome	0.000502	0.0133	CcSEcCtD
Letrozole—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000499	0.0132	CcSEcCtD
Letrozole—Fatigue—Metformin—polycystic ovary syndrome	0.000498	0.0132	CcSEcCtD
Letrozole—Constipation—Metformin—polycystic ovary syndrome	0.000494	0.0131	CcSEcCtD
Letrozole—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000476	0.0126	CcSEcCtD
Letrozole—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000474	0.00795	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000473	0.0125	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000465	0.0078	CbGpPWpGaD
Letrozole—Urticaria—Metformin—polycystic ovary syndrome	0.000459	0.0122	CcSEcCtD
Letrozole—Abdominal pain—Metformin—polycystic ovary syndrome	0.000457	0.0121	CcSEcCtD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000457	0.00766	CbGpPWpGaD
Letrozole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000453	0.00759	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000451	0.00756	CbGpPWpGaD
Letrozole—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000438	0.00734	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000432	0.00725	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000425	0.00712	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000421	0.00706	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000419	0.00702	CbGpPWpGaD
Letrozole—Asthenia—Metformin—polycystic ovary syndrome	0.000415	0.011	CcSEcCtD
Letrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.000409	0.00686	CbGpPWpGaD
Letrozole—Pruritus—Metformin—polycystic ovary syndrome	0.000409	0.0108	CcSEcCtD
Letrozole—CYP2A6—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.000407	0.00683	CbGpPWpGaD
Letrozole—Diarrhoea—Metformin—polycystic ovary syndrome	0.000395	0.0105	CcSEcCtD
Letrozole—Dizziness—Metformin—polycystic ovary syndrome	0.000382	0.0101	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00037	0.00621	CbGpPWpGaD
Letrozole—Vomiting—Metformin—polycystic ovary syndrome	0.000367	0.00973	CcSEcCtD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—polycystic ovary syndrome	0.000365	0.00612	CbGpPWpGaD
Letrozole—Rash—Metformin—polycystic ovary syndrome	0.000364	0.00965	CcSEcCtD
Letrozole—Dermatitis—Metformin—polycystic ovary syndrome	0.000364	0.00964	CcSEcCtD
Letrozole—Headache—Metformin—polycystic ovary syndrome	0.000362	0.00959	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000344	0.00577	CbGpPWpGaD
Letrozole—Nausea—Metformin—polycystic ovary syndrome	0.000343	0.00909	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00034	0.0057	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000336	0.00563	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000336	0.00563	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000332	0.00556	CbGpPWpGaD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000313	0.00524	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000299	0.00501	CbGpPWpGaD
Letrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000286	0.00479	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000279	0.00468	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000276	0.00462	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000275	0.00461	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000272	0.00457	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000271	0.00454	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000267	0.00448	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000265	0.00444	CbGpPWpGaD
Letrozole—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00026	0.00436	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000254	0.00425	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000247	0.00414	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000244	0.00409	CbGpPWpGaD
Letrozole—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000239	0.00401	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00023	0.00386	CbGpPWpGaD
Letrozole—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00023	0.00386	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00023	0.00385	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000227	0.0038	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000224	0.00375	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000222	0.00372	CbGpPWpGaD
Letrozole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000221	0.0037	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00022	0.00368	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000209	0.00351	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000209	0.00351	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000207	0.00346	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000206	0.00345	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000202	0.00339	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000197	0.0033	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000196	0.00329	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000183	0.00307	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.000175	0.00294	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000175	0.00294	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000167	0.00281	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000167	0.0028	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000166	0.00279	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000165	0.00277	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000164	0.00274	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000159	0.00266	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000157	0.00263	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000156	0.00261	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000154	0.00258	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000152	0.00255	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000147	0.00246	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000145	0.00243	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000144	0.00242	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000138	0.00231	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000136	0.00228	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000135	0.00226	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000129	0.00216	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000126	0.00212	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000126	0.00211	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000123	0.00207	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000123	0.00206	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000123	0.00206	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000122	0.00204	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00012	0.00201	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000118	0.00198	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000118	0.00198	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SUOX—polycystic ovary syndrome	0.000118	0.00198	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000117	0.00196	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000116	0.00195	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00011	0.00184	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—POMC—polycystic ovary syndrome	0.000109	0.00183	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000107	0.0018	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000103	0.00172	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	0.000102	0.00171	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.0001	0.00168	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	9.99e-05	0.00167	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	9.93e-05	0.00166	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	9.8e-05	0.00164	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	9.49e-05	0.00159	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LPCAT2—polycystic ovary syndrome	9.38e-05	0.00157	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SUOX—polycystic ovary syndrome	9.38e-05	0.00157	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TEAD2—polycystic ovary syndrome	9.32e-05	0.00156	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKR1C2—polycystic ovary syndrome	9.32e-05	0.00156	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	8.96e-05	0.0015	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	8.82e-05	0.00148	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	8.72e-05	0.00146	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ISYNA1—polycystic ovary syndrome	8.72e-05	0.00146	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—POMC—polycystic ovary syndrome	8.69e-05	0.00146	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	8.14e-05	0.00136	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	8.05e-05	0.00135	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	8.03e-05	0.00135	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PNPLA2—polycystic ovary syndrome	7.81e-05	0.00131	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	7.62e-05	0.00128	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TEAD2—polycystic ovary syndrome	7.42e-05	0.00124	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKR1C2—polycystic ovary syndrome	7.42e-05	0.00124	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	7.4e-05	0.00124	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SRD5A1—polycystic ovary syndrome	7.4e-05	0.00124	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	7.21e-05	0.00121	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	7.11e-05	0.00119	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—STAR—polycystic ovary syndrome	7.06e-05	0.00118	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	6.71e-05	0.00113	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	6.7e-05	0.00112	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	6.61e-05	0.00111	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMMR—polycystic ovary syndrome	6.29e-05	0.00106	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PNPLA2—polycystic ovary syndrome	6.21e-05	0.00104	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HSD3B1—polycystic ovary syndrome	6e-05	0.00101	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	6e-05	0.00101	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.93e-05	0.000995	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SRD5A1—polycystic ovary syndrome	5.89e-05	0.000988	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.63e-05	0.000943	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—STAR—polycystic ovary syndrome	5.62e-05	0.000942	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LHB—polycystic ovary syndrome	5.47e-05	0.000918	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HSD3B2—polycystic ovary syndrome	5.35e-05	0.000897	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	5.3e-05	0.000889	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.23e-05	0.000877	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	5.18e-05	0.000869	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMMR—polycystic ovary syndrome	5.01e-05	0.00084	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSD3B1—polycystic ovary syndrome	4.78e-05	0.000801	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	4.77e-05	0.0008	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	4.62e-05	0.000775	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	4.45e-05	0.000747	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LHB—polycystic ovary syndrome	4.36e-05	0.000731	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	4.28e-05	0.000717	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.28e-05	0.000717	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSD3B2—polycystic ovary syndrome	4.26e-05	0.000714	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.25e-05	0.000713	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	4.22e-05	0.000708	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.22e-05	0.000707	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.19e-05	0.000703	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKR1C1—polycystic ovary syndrome	4.13e-05	0.000692	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	3.99e-05	0.000669	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	3.93e-05	0.000659	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SULT2A1—polycystic ovary syndrome	3.8e-05	0.000637	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.76e-05	0.000631	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—RRM2—polycystic ovary syndrome	3.68e-05	0.000616	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—YAP1—polycystic ovary syndrome	3.54e-05	0.000594	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.44e-05	0.000577	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.44e-05	0.000577	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NAMPT—polycystic ovary syndrome	3.41e-05	0.000571	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TH—polycystic ovary syndrome	3.4e-05	0.00057	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	3.36e-05	0.000564	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	3.31e-05	0.000554	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.2e-05	0.000536	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.19e-05	0.000534	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	3.18e-05	0.000532	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	3.13e-05	0.000524	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	2.77e-05	0.000465	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.72e-05	0.000456	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.72e-05	0.000456	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TH—polycystic ovary syndrome	2.7e-05	0.000454	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	2.64e-05	0.000443	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	2.63e-05	0.000441	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	2.51e-05	0.00042	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	2.47e-05	0.000415	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	2.34e-05	0.000392	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.28e-05	0.000382	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	2.21e-05	0.00037	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.16e-05	0.000362	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	2.1e-05	0.000353	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.06e-05	0.000346	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	1.99e-05	0.000334	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	1.89e-05	0.000318	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	1.87e-05	0.000313	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	1.86e-05	0.000312	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—INS—polycystic ovary syndrome	1.86e-05	0.000311	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.84e-05	0.000308	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.75e-05	0.000294	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.6e-05	0.000268	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.56e-05	0.000262	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.51e-05	0.000254	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	1.51e-05	0.000253	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	1.49e-05	0.000249	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—INS—polycystic ovary syndrome	1.48e-05	0.000248	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.39e-05	0.000233	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.35e-05	0.000226	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.3e-05	0.000218	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.25e-05	0.000209	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.23e-05	0.000207	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.16e-05	0.000195	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.15e-05	0.000192	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TH—polycystic ovary syndrome	9.92e-06	0.000166	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	9.65e-06	0.000162	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	9.07e-06	0.000152	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.1e-06	0.000136	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	7.71e-06	0.000129	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.31e-06	0.000123	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	6.82e-06	0.000114	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.53e-06	9.27e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.45e-06	9.14e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.42e-06	9.09e-05	CbGpPWpGaD
